Nara Mold and DIE나라엠앤디

Nara Mold and Die is loss-making on a trailing basis, with a share price down about 45% over the past year and heavy debt relative to equity.

Trailing twelve-month figures to H1 2026 show revenue of about ₩184B, an operating loss of about ₩4.3B and a small net profit of about ₩0.3B, with free cash flow of roughly -₩10.5B. Borrowings of about ₩82B exceed cash of about ₩19B, and liabilities are about 165% of equity. The company profile was not included in the data, so the business description is limited to the financial and filing data.

What stands out

• Revenue has fallen from about ₩231B in 2023 to about ₩185B in 2025, and the trailing figure is about ₩184B.
• Operating income turned from about ₩10.7B in 2023 to roughly break-even in 2025 and a loss of about ₩4.3B on a trailing basis.
• The trailing net profit of about ₩0.3B is small and sits well above the operating loss, so non-operating items likely mattered, but the data does not break this down.
• At ₩2,405 the shares are near the lower end of their 52-week range of ₩2,255 to ₩4,525, and the market value is about ₩34B.
• The data shows a DCF base value of ₩56 against a bull value of ₩10,826 and a bear value of ₩0; this model output is not a forecast and the wide range makes it hard to rely on.

What to watch

• The full-year 2026 results and the next quarterly report, to see whether the operating loss and negative free cash flow continue.
• Debt levels against cash, since borrowings of about ₩82B are well above cash of about ₩19B.
• Continued insider shareholding reports and the foreign ownership trend, which fell from 2.8% to 2.3% over the past 60 days; the data does not explain the reasons.